Avidity Biosciences Investor Relations Material
Latest events
Study Update
Avidity Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avidity Biosciences Inc
Access all reports
Avidity Biosciences Inc is a biopharmaceutical company focused on developing a novel class of RNA therapeutics. These therapeutics, known as Antibody Oligonucleotide Conjugates (AOC™), are designed to target and treat a range of serious diseases by combining the specificity of monoclonal antibodies with the precision of oligonucleotides. This approach aims at addressing diseases previously untreatable with RNA therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Key slides for Avidity Biosciences Inc
Investor Update
Avidity Biosciences Inc
Investor Update
Avidity Biosciences Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
RNA
Country
🇺🇸 United States